Surgalign Holdings stock reports a 0.25 percent yield

Surgalign Holdings stock carries a 0.25 percent shareholder yield for 2026, down from 0.69 percent in 2025, a 63.78 percent year-over-year decline reported on September 23, 2026, by IT Boltwise. The metric measures shareholder distributions and share repurchases against a company market value.

Yield falls 63.78 percent

Eulerpool also lists Surgalign Holdings at a 0.25 percent shareholder yield in 2026, compared with 0.69 percent in 2025. That comparison places the annual change at negative 63.78 percent and makes capital returns the clearest quantified indicator in the recent company coverage.

The figures describe a change in shareholder-return capacity rather than operating revenue or earnings. They therefore belong to the capital-allocation side of the investment case and should not be treated as a substitute for a fresh income statement.

Spinal products anchor the business

Surgalign's investor-relations page describes the company as a global medical technology business focused on digital health and surgical care. Its portfolio covers spinal implants, fixation systems, interbody fusion products, motion-preservation devices and digital surgery technologies, with distribution across international markets, according to the Surgalign investor-relations page.

A separate September 10, 2026 market page identifies ESGRO.US as Surgalign Holdings shares on Nasdaq, while the SRGA quote record identifies SRGA as an inactive symbol. The distinction matters because historical SRGA references and current company descriptions can point to different trading identifiers.

Capital returns define the latest signal

Surgalign Holdings stock carries the 0.25 percent shareholder yield cited for 2026, dated September 23, 2026. The 0.44 percentage-point gap from the 2025 figure of 0.69 percent gives investors a concrete measure of how the shareholder-return profile changed across the two reported years.